Commission Implementing Regulation (EU) 2022/1252 of 19 July 2022 amending Implementing Regulation (EU) 2015/408 to update the list of candidates for substitution (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2022/1252
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) 2015/408 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

In the Annex to Implementing Regulation (EU) 2015/408 the following entries are deleted:

amitrole;

bifenthrin;

bromadiolone;

carbendazim;

carbetamide;

copper compounds (variants copper hydroxide, copper oxychloride, copper oxide, Bordeaux mixture and tribasic copper sulphate);

cyproconazole;

difenacoum;

dimethoate;

diquat;

epoxiconazole;

esfenvalerate;

ethoprophos;

etoxazole;

famoxadone;

fenamiphos;

fenbutatin oxide;

fipronil;

fluquinconazole;

glufosinate;

haloxyfop-P;

imazamox;

imazosulfuron;

isoproturon;

isopyrazam;

lambda-cyhalothrin;

linuron;

lufenuron;

mecoprop;

methomyl;

metsulfuron-methyl;

molinate;

myclobutanil;

oxadiargyl;

oxadiazon;

pendimethalin;

prochloraz;

profoxydim;

propiconazole;

prosulfuron;

quinoxyfen;

quizalofop-P (variant quizalofop-P-tefuryl);

tepraloxydim;

thiacloprid;

triasulfuron;

triazoxide;

warfarin.